IPO
IPO
Best Performers
Forthcoming Issues
Closed Issues
New Listings
Current Issues
IPO Performance
IPO News
IPO Analysis
Basis of Allotment
Draft Prospectus
  HOME  >  IPO  >   IPO SNAPSHOT
IPO Snapshot    
Anondita Medicare Ltd.
Issue Open Date 22-Aug-25  
Issue Closing Date 26-Aug-25  
Application Money 100  
Allotment Money  
Price Band 137 - 145  
Minimium Application No. 2000  
Issue Size (Shares) 3443000  
Market Lot 1.00  
Objective
1. Funding capital expenditure requirements for the purchase of equipment/machineries;2. Funding the working capital requirements of our Company;3. To meet out the expenses for Unidentified Acquisition and General Corporate Purposes.
Category No. of Shares No. of Shares Subscription Ratio
  Offered / Reserved Bid For  
Non-Institutional Investors     362463000   NA  
Qualified Institutional Buyers     138648000   NA  
Retail Individual Investors     454242000   NA  
Business Description
Further, as we gained experience in the industry and having supplied our products to various pharma companies for last many years, we decided to venture out in the market by launching our own brand of condoms under the name of Cobra Condoms. Our new brand is 1
more...
Promoter's Holding
Total Share Capital   11160599  
Offered to Public   3443000  
Promoter's Holding (Pre-Issue)   83.95  
Promoter's Holding (Post-Issue)   61.71  
Address
Flat No.704
Narmada Block
N6
Sec- D
Pkt-6
Vasant Kunj
New Delhi ,
Delhi ,
110070
Phone: 7678182056
Email: info@anonditamedicare.com
Website: www.anonditamedicare.com
Registrar
Maashitla Securities Pvt Ltd.
451
Krishna Apra Business
Square
Netaji Subhash Place

Pitampura
New Delhi
Listed at
NSE
Lead Manager
Narnolia Financial Services Ltd.
Promoters
Anupam Ghosh
Reshant Ghosh
Sonia Ghosh
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.